Bharat Biotech slams critics for raising doubt on Covaxin’s efficacy

A day after the DCGI’s decision to approve Covaxin kicked up a major row with a string of experts pointing to the lack of its efficacy data, its developer Bharat Biotech hit out on Monday at critics asserting that the company was in “no way” inferior to Pfizer, a US pharma MNC, in terms of coronavirus vaccine.

Read Full Story>>